News – Page 477 – Endpoints News

House passes historic drug pricing reforms, lining up decades-in-the-making win for Biden and Democrats

3 years ago

Do pharma TV and social ads work? Pharma marketing agencies adopting new tech solutions to find out

3 years ago

Pear Therapeutics touts Q2 growth while scaling back full-year goals and chopping 9% of staff

3 years ago

Senate Finance chair continues his investigation into pharma taxes with requests for Amgen

3 years ago

Paving the way for Merck's buyout, Seagen loses arbitration dispute with Daiichi Sankyo over ADC tech

3 years ago

Abbott pumps $450M+ into new Ireland-based manufacturing site project and hiring spree

3 years ago

FDA approves second indication for AstraZeneca and Daiichi's Enhertu in less than a week

3 years ago

J&J to remove talc products from shelves worldwide, replacing with cornstarch-based portfolio

3 years ago

CSL brings Seqirus, Vifor under parent umbrella brand in identity revamp

3 years ago

Checkpoint ends trial due to Russian invasion; Terns lines up more cash for NASH

3 years ago

‘The placebo caught up’: Months after diabetic nerve pain fail, Aptinyx sees another pain trial fall through

3 years ago

Bolt throws a wrench in the pipeline, looking to conserve cash

3 years ago

Unity finds itself with a finite amount of cash as new data provide a ray of hope for investors

3 years ago

Larimar to respond to FDA this quarter on 15-month clinical hold of PhI Friedreich's ataxia drug

3 years ago

Gold for adults, silver for infants: Pfizer's Prevnar 2.0 headed to FDA months after Merck's green light

3 years ago

Cerevel's Tony Coles is still counting his money as a rival's boost helps fuel a potential $609M windfall

3 years ago

CEO of Doudna spinout: Within five years, genome editors will have a 'really big impact' on patients' lives

3 years ago

Blasting 'speculative commentary,' GSK offers update on Zantac litigation and vows to 'vigorously defend itself'

3 years ago

Novartis reports two patient deaths after treatment with Zolgensma

3 years ago

As Covid program advances, Enanta's new CMO says it's not 'limited to antivirals'; With all eyes on Gilead-partnered ...

3 years ago

Sanofi, GSK, Haleon see stock prices dip and dive amid litigation for recalled heartburn drug

3 years ago

FDA converts Novartis' NSCLC drug to a full approval with confirmatory data

3 years ago

Belldegrun-backed real estate development group blueprints a new biotech campus — this time in Boulder

3 years ago

More than half a billion Covid vaccine doses wasted after Emergent's Baltimore fiasco

3 years ago

First page Previous page 474 475 476477478 479 480 Next page Last page